novo nordisk glp-1 GLP-1s for Alzheimer's: announces trial conclusion A New Era of Weight

Here, we provide a comprehensive review of the therapeutic potential of incretin mimetics and insulin in AD and PD.

Once weekly

The review urges nurse practitioners to balance expanding clinical promise with careful prescribing, patient education, monitoring, access advocacy, and vigilance for gastrointestinal, endocrine, pregnancy-related, and rare serious risks.

An increasing number of patients treated with novel antidiabetic drugs, including glucagon-like-peptide-1 receptor agonists (GLP-1RA), dual glucose-dependent insulinotropic polypeptide receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are presenting in the perioperative...

Discover how science-backed supplements can make a difference

Additionally, we highlight the gaps for further studies in clinical applications of GLP-1 RAs in aging-related diseases